Newsfeeds Archive - Page 2 of 5

3 minute read

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

September 25, 1:04 PM

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

3 minute read

Nasdaq Turns Higher; SCYNEXIS Shares Plunge

By Lisa Levin

September 25, 12:12 PM

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500 also rose, gaining, 0.22% to 4,329.75.

BCLI

1 minute read

Why Are Antifungal Focused Scynexis Stock Plunging Today?

By Vandana Singh

September 25, 11:53 AM

Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga

GSK

3 minute read

U.S. Stocks Open Lower; Chicago Fed Index Falls In August

By Lisa Levin

September 25, 9:58 AM

U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the market opening Monday, the Dow traded down 0.26% to 33,875.83 while the NASDAQ fell 0.05% to 13,205.29. The S&P 500 also fell, dropping, 0.13% to 4,314.62.

BCLI

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

September 25, 9:06 AM

Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 76.2% to $1.17 during Monday’s pre-market session. The company’s market cap…

ACRX

2 minute read

Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

August 16, 8:19 AM

Gainers

$SRM

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

August 15, 9:06 AM

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 91.7% to $5.98 during Tuesday’s pre-market session. The company’s market cap…

DCTH

2 minute read

SCYNEXIS And Hansoh Pharma Announce NMPA Acceptance Of The New Drug Application For Ibrexafungerp In China

By Happy Mohamed

July 20, 9:59 AM

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China's National Medical Products

SCYX

2 minute read

SCYNEXIS Reports Closing Of Exclusive License Agreement With GSK For BREXAFEMME; SCYNEXIS Is Receiving An Upfront Payment Of $90M With Future Performance-Based Milestone Payments Of Up To $503M And Tiered Royalties

By Happy Mohamed

May 12, 8:03 AM

SCYNEXIS is receiving an upfront payment of $90 million with future performance-based milestone payments of up to $503 million and tiered royalties. GSK obtains the exclusive rights to

GSK

1 minute read

Earnings

SCYNEXIS: Q1 Earnings Insights

By Benzinga Insights

May 11, 8:20 AM

SCYNEXIS (NASDAQ:SCYX) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:00 AM. Here’s what investors…

SCYX